Literature DB >> 30154634

Long-Term Results of Endovascular Femoropopliteal Interventions.

Robert Hacker1, Luke Marone2.   

Abstract

Background and Objective  Short-term results of endovascular intervention for femoropopliteal lesions have been extensively reported; however, there exists a paucity of long-term objective data related to outcomes of these interventions. We sought to characterize these long-term results including patency, limb salvage, and mortality. Methods  From May 2003 to July 2009, all patients who underwent technically successful endovascular balloon angioplasty and/or stenting for Trans-Atlantic Inter-Societal Consensus (TASC) II B, C, and D lesions were identified in a retrospective fashion. Patient demographics, clinical characteristics, arterial noninvasive data, and angiographic anatomic data were evaluated. Results  A total of 236 limbs in 186 patients (mean age 74, range 37-94) were treated. Lesion distributions by TASC II classification B, C, and D were 121 (51.3%), 37 (15.7%), and 78 (33%), respectively. Critical limb ischemia (CLI) was the indication for intervention in 42.4% of patients. Five-year primary and primary-assisted patency rates stratified by TASC II classification were B: 55.1%, 91.9%; C: 37.4%, 74.6%; D: 35.5%, 67%, respectively ( p  = 0.23). Secondary patency based on TASC II classification was B: 92.9%, C: 83%, and D: 75.9%, respectively. Univariate analysis identified age > 75, CLI, and cerebrovascular disease as predictors for loss of patency. Reinterventions to maintain patency were required in 26.5% of TASC II B, 43.2% of TASC II C, and 25.6% of TASCII D lesions ( p  = NS) and mean time to reintervention ranged from 22 to 29 months with no significant difference related to TASC II classification. A total of eight limbs (3.38%) were converted to open revascularization with two (0.85%) having a change in their initial preoperatively identified bypass target site. Three limbs (1.27%) required a major amputation during follow-up. Survival at 5 years was 44.3%; CLI and smoking were identified as risk factors for death (hazard ratio [HR] 2.6, 1.75-3.84, p  < 0.001, HR 3.33, 1.70-6.52, p  < 0.001), respectively. Conclusion  Long-term patency of endovascular interventions for complicated femoropopliteal lesions is acceptable across TASC II classification and is associated with excellent limb salvage. Mortality in this patient cohort is significant with CLI and smoking being identified as predictors of death.

Entities:  

Keywords:  SFA disease; TASC II; amputation; iliofemoral occlusive disease; limb salvage; stenting; tibioperoneal disease

Year:  2018        PMID: 30154634      PMCID: PMC6103768          DOI: 10.1055/s-0038-1629923

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  13 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Long-term outcome of femoropopliteal stenting. Results of a prospective study.

Authors:  E Schönefeld; G Torsello; N Osada; M Herten; T Bisdas; K P Donas
Journal:  J Cardiovasc Surg (Torino)       Date:  2013-10       Impact factor: 1.888

3.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

4.  Percutaneous endovascular treatment for chronic limb ischemia.

Authors:  Albeir Mousa; Jason Y Rhee; Susan M Trocciola; Rajeev Dayal; Robert B Beauford; Naveen Kumar; Peter Henderson; James McKinsey; Nicholas J Morrissey; K Craig Kent; Peter L Faries
Journal:  Ann Vasc Surg       Date:  2005-03       Impact factor: 1.466

5.  Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease.

Authors:  Hideaki Aihara; Yoshimitsu Soga; Shinsuke Mii; Jin Okazaki; Terutoshi Yamaoka; Daisuke Kamoi; Yoshiaki Shintani; Toshinobu Ishikawa
Journal:  Circ J       Date:  2013-11-29       Impact factor: 2.993

6.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

Authors:  F G Fowkes; E Housley; E H Cawood; C C Macintyre; C V Ruckley; R J Prescott
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

7.  Safety and efficacy of the frontrunner XP catheter for recanalization of chronic total occlusion of the femoropopliteal arteries.

Authors:  Ranjan Shetty; G Vivek; Ashok Thakkar; Rajaram Prasad; Umesh Pai; Krishnananda Nayak
Journal:  J Invasive Cardiol       Date:  2013-07       Impact factor: 2.022

8.  Popliteal versus tibial retrograde access for subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) technique.

Authors:  W R Hua; M Q Yi; T L Min; S N Feng; L Z Xuan; J Xing
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-06-10       Impact factor: 7.069

9.  Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss.

Authors:  J Lantis; M Jensen; A Benvenisty; D Mendes; C Gendics; G Todd
Journal:  Ann Vasc Surg       Date:  2008 May-Jun       Impact factor: 1.466

10.  Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.

Authors:  Donald T Baril; Luke K Marone; Justine Kim; Michael R Go; Rabih A Chaer; Robert Y Rhee
Journal:  J Vasc Surg       Date:  2008-09       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.